8-K filing — Fly-E Group, Inc. (FLYE)
Filed: 2026-11-04 AccNo: 0001213900-26-116000 Size: 193 KB Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Stocks · News reference
Dow Falls Over 100 Points; US Initial Jobless Claims Decline
U.S. stocks fell Thursday, led by tech, while energy rose and oil jumped 4.8%. Jobless claims eased to 197,000; small caps posted sharp swings.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Sunshine Biopharma Inc. Scheduled to Announce Q3 2026 Financial Results
Sunshine Biopharma Inc. has scheduled the release of its third-quarter 2026 financial results for November 10, 2026.
Medicus Pharma Ltd. Regains Compliance with Nasdaq Minimum Bid Price Requirement
Medicus Pharma Ltd. announced that it has received notification from Nasdaq confirming it has regained compliance with the exchange's $1.00 minimum bid price requirement.
China SXT Pharmaceuticals Announces 1-for-100 Reverse Stock Split
China SXT Pharmaceuticals, Inc. announced it will implement a 1-for-100 reverse stock split of its Class A ordinary shares, effective October 26, 2026.
Sunshine Biopharma Announced 1-20 Reverse Stock Split Effective Oct. 26
China SXT Pharmaceuticals Inc. Announces Termination of Additional Purchase Right
China SXT Pharmaceuticals, Inc. has terminated the right of purchasers to acquire up to an additional $12 million in shares or pre-funded warrants from its October 8, 2026, registered direct offering.